463 Metastatic gastric cancer patient benefiting from combined radio-immunotherapy treatment displayed sustained anti-NY-ESO-1 specific T cells and expressed important immuno-modulatory markers

Maysaloun Merhi; Afsheen Raza; Varghese Inchakalody; Siveen Kodappully; Deepak Choubey; Fairooz Sahir; Sarra Mestiri; Shereena Hydrose; Niloofar Allahverdi; Munir Jalis; Allan Relecom; Lobna Al-Zaidan; Mohamed Sir Elkhatim Hamid; Mai Mostafa; Abdul Rehman Zar Gul; Shahab Uddin; Mohammed Ussama Al Homsi; Maysaloun Merhi; Said Dermine

doi:10.1136/jitc-2020-SITC2020.0463

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Alerts

PDF

Regular and young investigator award abstracts

Combination immunotherapies

463 Metastatic gastric cancer patient benefiting from combined radio-immunotherapy treatment displayed sustained anti-NY-ESO-1 specific T cells and expressed important immuno-modulatory markers

Log in using your username and password

Main menu

Log in using your username and password

You are here

Read the full text or download the PDF:

Log in using your username and password